Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge

The U.S. Supreme Court delivered a landmark victory for Bayer by ruling that federal pesticide regulations prevent many state-level lawsuits claiming the company failed to warn consumers that Roundup weedkiller causes cancer. The 7-2 decision is expected to significantly reduce the number of pending Roundup lawsuits and strengthens Bayer’s legal position after years of costly litigation.

The case centered on John Durnell, a Missouri man who developed non-Hodgkin lymphoma after using Roundup for nearly two decades while maintaining parks in St. Louis. A Missouri jury awarded him $1.25 million in 2023, and the verdict was later upheld on appeal. However, the Supreme Court overturned the ruling, agreeing with Bayer that federal law governing pesticide labeling takes precedence over state failure-to-warn claims.

Justice Brett Kavanaugh, writing for the majority, noted that the U.S. Environmental Protection Agency (EPA) has repeatedly concluded that glyphosate, the active ingredient in Roundup, is not carcinogenic and has never required a cancer warning on the product’s label. According to the ruling, Bayer cannot be forced by state law to include warnings that conflict with EPA-approved labeling requirements.

Justice Ketanji Brown Jackson, joined by Justice Neil Gorsuch in dissent, argued that Missouri’s warning requirements were consistent with federal law and criticized the decision for limiting consumers’ ability to seek compensation through state courts.

Following the ruling, Bayer shares jumped nearly 19%, reflecting investor optimism that the long-running Roundup litigation may finally be nearing its end. Since acquiring Monsanto for $63 billion in 2018, Bayer has faced more than 100,000 lawsuits alleging that glyphosate exposure caused cancer. The company has consistently denied those claims, citing repeated EPA findings that Roundup does not pose a cancer risk when used as directed.

Bayer previously removed glyphosate from the consumer version of Roundup and announced a proposed $7.25 billion settlement earlier this year to resolve thousands of current and future claims. Company CEO Bill Anderson welcomed the Supreme Court’s decision, saying it removes a major legal burden and allows Bayer to refocus on its core pharmaceutical and agricultural businesses.

Environmental organizations strongly criticized the ruling, arguing it weakens consumer protections and limits legal options for individuals who believe they were harmed by glyphosate exposure. Despite the decision, legal experts note that some Roundup-related cases remain active, although future lawsuits are expected to face much greater legal hurdles.

The Supreme Court ruling marks one of the most significant developments in the long-running Roundup litigation and could reshape how pesticide labeling disputes are handled across the United States.